Evidence map›Paper›PMID 33596864›Full record

ArticleBMC cancer2021

Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains.

Manon Oliero, Annie Calvé, Gabriela Fragoso, Thibault Cuisiniere, Roy Hajjar, Ulrich Dobrindt, Manuela M Santos

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Contribution of pks+Microorganisms · 2024
    Review
  11. Current understandings of colibactin regulation.Microbiology (Reading, England) · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Manon OlieroNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada.
Annie CalvéNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada.
Gabriela FragosoNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada.
Thibault CuisiniereNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada.
Roy HajjarNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada.
Ulrich DobrindtInstitute of Hygiene, Section Microbial Genome Plasticity, University of Münster, Mendelstraße 7, 48149, Münster, Germany.
Manuela M SantosNutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 Rue Saint Denis, Montreal, QC, H2X 0A9, Canada. manuela.santos@umontreal.ca.ORCID http://orcid.org/0000-0003-3497-0585
Centre Hospitalier de l’Université de Montréal · CACegep Edouard Montpetit · CAUniversity of Münster · DE

Funding

CIHR PJT-159775Fonds de Recherche du Québec - Santé MSSS Resident Physician Health Research Career Training ProgramInstitut du Cancer de Montréal scholarshipInterdisciplinary Center for Clinical Research of the Medical Faculty Münster Dob2/013/12Natural Sciences and Engineering Research Council of Canada RGPIN-2018-06442Université de Montréal scholarship
6 · The paper itself

Abstract

backgroundColibactin is a genotoxin that induces DNA double-strand breaks that may lead to carcinogenesis and is produced by Escherichia coli strains harboring the pks island. Human and animal studies have shown that colibactin-producing gut bacteria promote carcinogenesis and enhance the progression of colorectal cancer through cellular senescence and chromosomal abnormalities. In this study, we investigated the impact of prebiotics on the genotoxicity of colibactin-producing E. coli strains Nissle 1917 and NC101.

methodsBacteria were grown in medium supplemented with 20, 30 and 40 mg/mL of prebiotics inulin or galacto-oligosaccharide, and with or without 5 μM, 25 μM and 125 μM of ferrous sulfate. Colibactin expression was assessed by luciferase reporter assay for the clbA gene, essential for colibactin production, in E. coli Nissle 1917 and by RT-PCR in E. coli NC101. The human epithelial colorectal adenocarcinoma cell line, Caco-2, was used to assess colibactin-induced megalocytosis by methylene blue binding assay and genotoxicity by γ-H2AX immunofluorescence analysis.

resultsInulin and galacto-oligosaccharide enhanced the expression of clbA in pks+ E. coli. However, the addition of 125 μM of ferrous sulfate inhibited the expression of clbA triggered by oligosaccharides. In the presence of either oligosaccharide, E. coli NC101 increased dysplasia and DNA double-strand breaks in Caco-2 cells compared to untreated cells.

conclusionOur results suggest that, in vitro, prebiotic oligosaccharides exacerbate DNA damage induced by colibactin-producing bacteria. Further studies are necessary to establish whether oligosaccharide supplementation may lead to increased colorectal tumorigenesis in animal models colonized with pks+ E. coli.

Indexed as

DNA DamageCaco-2 CellsCarcinogenesisCellular SenescenceColonic NeoplasmsEscherichia coliGenomic IslandsHumansMutagensOligosaccharidesPeptidesPolyketidescolibactinMutagensOligosaccharidesPeptidesPolyketidesColibactinColorectal cancerE. coliGalacto-oligosaccharidesGenotoxinInulinIron

Identifiers

PMID33596864
PMCPMC7890614
OpenAlexW3131632038

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.